Skip to main content

and
Your search also matched 16 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

The Elevated Serum S100A8/A9 During Acute Myocardial Infarction Is Not of Cardiac Myocyte Origin

Include preview-only content
  1. Article

    Classification of 5-HT1A receptor agonists and antagonists using GA-SVM method

    To construct a reliable computational model for the classification of agonists and antagonists of 5-HT1A receptor.

    Xue-lian Zhu, Hai-yan Cai, Zhi-jian Xu, Yong Wang in Acta Pharmacologica Sinica (2011)

  2. Article

    Clinical and Molecular Features of 38 Children with Chronic Granulomatous Disease in Mainland China

    Chronic granulomatous disease (CGD) is an inherited disorder, with phagocytes failing to produce antimicrobial superoxide due to deficient NADPH oxidase activity. Mutations in the gene encoding CYBB are respon...

    Huan Xu, Wen Tian, Shu-Juan Li, Lu-Ying Zhang, Wei Liu in Journal of Clinical Immunology (2014)

  3. Article

    Erratum to: Clinical and Molecular Features of 38 Children with Chronic Granulomatous Disease in Mainland China

    Huan Xu, Wen Tian, Shu-Juan Li, Lu-Ying Zhang, Wei Liu in Journal of Clinical Immunology (2017)

  4. Article

    Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution

    Shenmai injection (SMI) is a Chinese patent-protected injection, which was mainly made of Red Ginseng and Radix Ophiopogonis and widely used for treating coronary heart disease and tumors by boosting Qi and no...

    Wen-yue Liu, **g-wei Zhang, Xue-quan Yao, Chao Jiang in Acta Pharmacologica Sinica (2017)

  5. Article

    Preclinical evaluation of the efficacy, pharmacokinetics and immunogenicity of JS-001, a programmed cell death protein-1 (PD-1) monoclonal antibody

    JS-001 is the first monoclonal antibody (mAb) against programmed cell death protein-1 (PD-1) approved by the China Food and Drug Administration (CFDA) into the clinical trails. To date, however, no pre-clinica...

    Jie Fu, Fang Wang, Li-hou Dong, **g Zhang, Cheng-lian Deng in Acta Pharmacologica Sinica (2017)

  6. Article

    Open Access

    A Cohort Study on Deficiency of ADA2 from China

    Deficiency of adenosine deaminase 2 (DADA2), an autosomal recessive autoinflammatory disorder caused by biallelic loss-of-function variants in adenosine deaminase 2 (ADA2), has not been systemically investigat...

    Guo-min Li, Xu Han, Ye Wu, Wei Wang, Hong-xia Tang in Journal of Clinical Immunology (2023)